791 results on '"Regazzoli, Damiano"'
Search Results
152. Severe Valvular Heart Disease and COVID-19: Results from the Multicenter International Valve Disease Registry
153. Role of Different Antithrombotic Regimens after Percutaneous Left Atrial Appendage Occlusion: A Large Single Center Experience
154. MitraClip After Failed Surgical Mitral Valve Repair—An International Multicenter Study
155. Minimally-invasive device-based approaches for improving cardiac perfusion
156. Contributors
157. Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis:Insights From the BEAT International Collaborative Registrys
158. Complex Femoral Accesses
159. Lower extremities arterial disease: not a peripheral issue
160. The Growing Role of Transcatheter Electrosurgery
161. Computed tomography analysis of coronary ostia location following valve‐in‐valve transcatheter aortic valve replacement with the ACURATE neo valve: Implications for coronary access
162. Procedural and clinical outcomes of type 0 versus type 1 bicuspid aortic valve stenosis undergoing trans-catheter valve replacement with new generation devices: Insight from the BEAT international collaborative registry
163. Left atrial appendage occlusion in patients with atrial fibrillation: focus on current evidence and commercially available devices
164. Vascular complications after transcatheter aortic valve implantation: treatment modalities and long-term clinical impact.
165. Management of myocardial revascularisation failure: an expert consensus document of the EAPCI
166. Outcome of transcatheter aortic valve replacement in bicuspid aortic valve stenosis with new-generation devices
167. Percutaneous Treatment of Paravalvular Leak in Rapid-Deployment Bioprosthetic Aortic Valve With Balloon Dilation
168. Future Perspectives in Percutaneous Treatment of Tricuspid Regurgitation
169. Management and outcomes of coronary artery perforations treated with the block and deliver technique
170. Percutaneous mitral valve repair in acute mitral regurgitation: case report and review of the literature
171. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19
172. Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality
173. Thin, Thinner, or Disappearing Stents?
174. Outcome of Coronary Ostial Stenting to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement
175. Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis
176. Multimodality Imaging of a Very Late Thrombosis of a Sutureless Aortic Prosthesis
177. Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement
178. [Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration]
179. Severe Mitral Stenosis and Persistent Left Appendage Thrombosis: When an Old Percutaneous Solution Meets New Percutaneous Strategies
180. Safety and efficacy of rotational atherectomy for the treatment of undilatable underexpanded stents implanted in calcific lesions
181. Dual Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation: Insights From the Milan Cohort
182. First-in-man Percutaneous LAA Closure With an Amplatzer Amulet and TriGuard Embolic Protection Device in a Patient With LAA Thrombus
183. Management and outcomes of coronary artery perforations treated with the block and deliver technique.
184. TCT-265 Percutaneous Coronary Interventions With Drug-Coated Balloons or Drug-Eluting Stents for the Treatment of Small Native Vessel Coronary Artery Disease: A Meta-Analysis of Randomized Trials
185. TCT-19 Outcome of Coronary Ostial Stenting to Prevent Coronary Obstruction During TAVR: An International Multicenter Registry
186. One‐stop‐shop totally percutaneous approach for severe aortic and mitral regurgitation in cardiogenic shock
187. Left Main Double Stenting for Patients with Cardiogenic Shock: The Faster the Better
188. Major Bleeding Associated With Very Early Subclinical Valve Thrombosis After Transcatheter Aortic Valve Replacement
189. Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment
190. Long‐term follow‐up of covered stent implantation for various coronary artery diseases
191. Transfemoral Implantation of a Balloon-Expandable Transcatheter Valve in a Rigid Mitral Annuloplasty Ring Optimized by Post-Dilatation
192. Sustained Reduction of Tricuspid Regurgitation After Percutaneous Repair With the MitraClip System in a Patient With a Dual Chamber Pacemaker
193. First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries
194. Comparing the Safety and Effectiveness of Five Leading New-Generation Devices for Transcatheter Aortic Valve Implantation: Twelve-Month Results From the RISPEVA Study.
195. Outcome of transcatheter aortic valve replacement in bicuspid aortic valve stenosis with new-generation devices.
196. A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience
197. Is Multislice Computed Tomography a Feasible Option for Follow-Up of Complex Coronary Lesions Treated With Bioresorbable Scaffolds?
198. Left main “Culotte in Culotte” to manage a trapped broken balloon
199. Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli: The TAVI-SMALL Registry.
200. Transcatheter aortic valve implantation in intermediate- and low-risk populations: An inevitable progression?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.